The increased breast cancer risk is greater for combined estrogen–progestin therapies than for estrogen-only therapies. Current evidence indicates similar breast cancer risks for different ...
Combined estrogen-progestin contraceptives, if prescribed, typically should not be started before 6 weeks postpartum, and only when lactation is well established and the infant's nutritional ...
Hormone changes related to menopause may directly contribute to ... and medical journals and associations. We only use quality, credible sources to ensure content accuracy and integrity.
another option that is often used in those with high background VTE risk is oral micronised progesterone with TD oestrogen. (Note dydrogesterone is also likely associated with a lower risk of VTE but ...
There seems to be no association between hormone therapy (HT) and glioma risk among U.S. women, according to a study published online Jan. 14 in Menopause. Jinyu Pan, from the Chongqing General ...
This means that they contain synthetic forms of the hormones estrogen and progesterone. The minipill only contains progestin, a synthetic form of progesterone. It also stops ovulation, alters the ...